115 related articles for article (PubMed ID: 11943954)
1. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
[TBL] [Abstract][Full Text] [Related]
2. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
3. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules in inflammatory bowel disease.
Jones SC; Banks RE; Haidar A; Gearing AJ; Hemingway IK; Ibbotson SH; Dixon MF; Axon AT
Gut; 1995 May; 36(5):724-30. PubMed ID: 7541009
[TBL] [Abstract][Full Text] [Related]
5. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
[TBL] [Abstract][Full Text] [Related]
7. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
[TBL] [Abstract][Full Text] [Related]
8. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
10. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.
Magro F; Araujo F; Pereira P; Meireles E; Diniz-Ribeiro M; Velosom FT
Dig Dis Sci; 2004 Aug; 49(7-8):1265-74. PubMed ID: 15387356
[TBL] [Abstract][Full Text] [Related]
11. [Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease].
Adamska I; Czerwionka-Szaflarska M; Kulwas A; Mierzwa G; Bała G; Rość D
Med Wieku Rozwoj; 2007; 11(4):413-8. PubMed ID: 18605194
[TBL] [Abstract][Full Text] [Related]
12. Plasma soluble vascular adhesion protein-1 concentration correlates with arterial stiffness: A cross-sectional study.
Chen DW; Zhao RM; Jin Y; Zhang J; Han C; Jiang SQ; Zheng HF; Wang JC
Arch Gerontol Geriatr; 2015; 61(1):67-71. PubMed ID: 25959807
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease.
Bernstein CN; Sargent M; Rawsthorne P; Rector E
Dig Dis Sci; 1997 Nov; 42(11):2338-49. PubMed ID: 9398815
[TBL] [Abstract][Full Text] [Related]
14. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.
Ward ST; Weston CJ; Shepherd EL; Hejmadi R; Ismail T; Adams DH
BMC Cancer; 2016 Feb; 16():154. PubMed ID: 26912327
[TBL] [Abstract][Full Text] [Related]
18. Circulating soluble adhesion molecules in inflammatory bowel disease.
Patel RT; Pall AA; Adu D; Keighley MR
Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1037-41. PubMed ID: 8680902
[TBL] [Abstract][Full Text] [Related]
19. Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.
Lin Z; Han M; Li H; Luo H; Zhang Y; Luo W
Clin Chim Acta; 2011 Aug; 412(17-18):1678-82. PubMed ID: 21645499
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease.
Sturm A; Schulte C; Schatton R; Becker A; Cario E; Goebell H; Dignass AU
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):445-50. PubMed ID: 10783999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
